Glucagon-like peptide 2 prevents down-regulation of intestinal multidrug resistance-associated protein 2 and P-glycoprotein in endotoxemic rats

Multidrug resistance-associated protein 2 (Mrp2, ABCC2) and P-glycoprotein (P-gp, ABCB1) constitute essential components of the intestinal biochemical barrier that prevent incorporation of food contaminants, drugs or toxic metabolites into the blood stream. Endotoxemia induced in rats by administrat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Arana, Maite Rocío (VerfasserIn) , Rigalli, Juan Pablo (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 23 August 2017
In: Toxicology
Year: 2017, Jahrgang: 390, Pages: 22-31
ISSN:1879-3185
DOI:10.1016/j.tox.2017.08.007
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1016/j.tox.2017.08.007
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0300483X17302330
Volltext
Verfasserangaben:Maite Rocío Arana, Guillermo Nicolás Tocchetti, Felipe Zecchinati, Ana Sofía Londero, Camila Dominguez, Virginia Perdomo, Juan Pablo Rigalli, Silvina Stella Maris Villanueva, Aldo Domingo Mottino

MARC

LEADER 00000caa a2200000 c 4500
001 1577646452
003 DE-627
005 20230426230654.0
007 cr uuu---uuuuu
008 180716s2017 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.tox.2017.08.007  |2 doi 
035 |a (DE-627)1577646452 
035 |a (DE-576)507646452 
035 |a (DE-599)BSZ507646452 
035 |a (OCoLC)1341013828 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Arana, Maite Rocío  |e VerfasserIn  |0 (DE-588)1163037036  |0 (DE-627)1027278167  |0 (DE-576)507752236  |4 aut 
245 1 0 |a Glucagon-like peptide 2 prevents down-regulation of intestinal multidrug resistance-associated protein 2 and P-glycoprotein in endotoxemic rats  |c Maite Rocío Arana, Guillermo Nicolás Tocchetti, Felipe Zecchinati, Ana Sofía Londero, Camila Dominguez, Virginia Perdomo, Juan Pablo Rigalli, Silvina Stella Maris Villanueva, Aldo Domingo Mottino 
264 1 |c 23 August 2017 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 16.07.2018 
500 |a Im Titel ist "P" in P-glycoprotein kursiv geschrieben 
520 |a Multidrug resistance-associated protein 2 (Mrp2, ABCC2) and P-glycoprotein (P-gp, ABCB1) constitute essential components of the intestinal biochemical barrier that prevent incorporation of food contaminants, drugs or toxic metabolites into the blood stream. Endotoxemia induced in rats by administration of bacterial lipopolysaccharide (LPS) results in elevated intestinal permeability and toxicity of xenobiotics in part associated with down-regulation of expression and activity of Mrp2 and P-gp. We evaluated the protective effect of glucagon-like peptide 2 (GLP-2), a peptide hormone with enterotrophic properties, on Mrp2 and P-gp alterations induced by single i.p. injection of LPS (5mg/kg b.wt.) to rats. Two different protocols of GLP-2 administration, namely prevention and reversion, were examined. The prevention protocol consisted of 7s.c. injections of GLP-2 (125μg/kg b.wt.) administered every 12h, starting 60h before LPS administration. The reversion protocol consisted of 2 doses of GLP-2, starting 3h after LPS injection. Intestinal samples were collected 24h after LPS administration and expression (protein and mRNA) and activity of Mrp2 were evaluated in proximal jejunum whereas those of P-gp were studied in ileum. GLP-2 completely neutralized down-regulation of expression of Mrp2 and P-gp and loss of their respective activities induced by LPS under prevention protocol. GLP-2 was also able to prevent internalization of both transporters from the apical membrane of the enterocyte to intracellular compartments, as detected by confocal microscopy. LPS induced an increase in IL-1β and oxidized glutathione tissue levels, which were also counterbalanced by GLP-2 administration. In contrast, the reversion protocol failed to attenuate Mrp2 and P-gp down-regulation induced by LPS. We conclude that GLP-2 can prevent down-regulation of intestinal expression and activity of Mrp2 and P-gp in endotoxemic rats and that IL-1β and oxidative stress constitute potential targets of GLP-2 protective effects. 
650 4 |a Cytokines 
650 4 |a GLP-2 
650 4 |a LPS 
650 4 |a Mrp-2 
650 4 |a Oxidative stress 
650 4 |a P-gp 
700 1 |a Rigalli, Juan Pablo  |e VerfasserIn  |0 (DE-588)1161690484  |0 (DE-627)1025156412  |0 (DE-576)506812332  |4 aut 
773 0 8 |i Enthalten in  |t Toxicology  |d Amsterdam [u.a.] : Elsevier Science, 1973  |g 390(2017), Seite 22-31  |h Online-Ressource  |w (DE-627)306710838  |w (DE-600)1500781-9  |w (DE-576)082436053  |x 1879-3185  |7 nnas  |a Glucagon-like peptide 2 prevents down-regulation of intestinal multidrug resistance-associated protein 2 and P-glycoprotein in endotoxemic rats 
773 1 8 |g volume:390  |g year:2017  |g pages:22-31  |g extent:10  |a Glucagon-like peptide 2 prevents down-regulation of intestinal multidrug resistance-associated protein 2 and P-glycoprotein in endotoxemic rats 
856 4 0 |u http://dx.doi.org/10.1016/j.tox.2017.08.007  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0300483X17302330  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180716 
993 |a Article 
994 |a 2017 
998 |g 1161690484  |a Rigalli, Juan Pablo  |m 1161690484:Rigalli, Juan Pablo  |d 50000  |e 50000PR1161690484  |k 0/50000/  |p 7 
999 |a KXP-PPN1577646452  |e 3017632334 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"pubHistory":["1.1973 - 302.2012; Vol. 303.2013 -"],"part":{"year":"2017","pages":"22-31","text":"390(2017), Seite 22-31","volume":"390","extent":"10"},"note":["Gesehen am 23.02.13"],"disp":"Glucagon-like peptide 2 prevents down-regulation of intestinal multidrug resistance-associated protein 2 and P-glycoprotein in endotoxemic ratsToxicology","type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"306710838","language":["eng"],"title":[{"title_sort":"Toxicology","title":"Toxicology","subtitle":"an international journal concerned with the effects of chemicals on living systems and immunotoxicology"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedKey":"1973","publisher":"Elsevier Science","dateIssuedDisp":"1973-","publisherPlace":"Amsterdam [u.a.]"}],"id":{"issn":["1879-3185"],"eki":["306710838"],"zdb":["1500781-9"]}}],"physDesc":[{"extent":"10 S."}],"id":{"eki":["1577646452"],"doi":["10.1016/j.tox.2017.08.007"]},"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"23 August 2017"}],"name":{"displayForm":["Maite Rocío Arana, Guillermo Nicolás Tocchetti, Felipe Zecchinati, Ana Sofía Londero, Camila Dominguez, Virginia Perdomo, Juan Pablo Rigalli, Silvina Stella Maris Villanueva, Aldo Domingo Mottino"]},"recId":"1577646452","language":["eng"],"note":["Gesehen am 16.07.2018","Im Titel ist \"P\" in P-glycoprotein kursiv geschrieben"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title_sort":"Glucagon-like peptide 2 prevents down-regulation of intestinal multidrug resistance-associated protein 2 and P-glycoprotein in endotoxemic rats","title":"Glucagon-like peptide 2 prevents down-regulation of intestinal multidrug resistance-associated protein 2 and P-glycoprotein in endotoxemic rats"}],"person":[{"display":"Arana, Maite Rocío","roleDisplay":"VerfasserIn","role":"aut","family":"Arana","given":"Maite Rocío"},{"given":"Juan Pablo","family":"Rigalli","role":"aut","display":"Rigalli, Juan Pablo","roleDisplay":"VerfasserIn"}]} 
SRT |a ARANAMAITEGLUCAGONLI2320